Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-02-27 @ 10:34 AM
Study NCT ID:
NCT00985660
Status:
COMPLETED
Last Update Posted:
2009-09-28
First Post:
2009-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg
Sponsor:
Mylan Pharmaceuticals Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2007-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-07
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-24
First Submit QC Date:
None
Study First Post Date:
2009-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-09-25
Last Update Post Date:
2009-09-28
Last Update Post Date Type:
ESTIMATED